CRPF GDMO Recruitment 2021: Applications for 54 posts open; walk-in interviews to be held on 13 May

-

CRPF GDMO Recruitment 2021: The Central Reserve Police Force (CRPF) has started the recruitment drive to fill 50 General Duty Medical Officers (GDMO) posts in various CRPF units/GC/CHs/Institutions across the country.  The walk-in interviews are scheduled to be held on 13 May.

The recruitment will be on a contractual basis for one year and the remuneration for shortlisted candidates has been finalised at Rs 75,000 per month, the official notification said. The posts are open for both male and female aspirants.

Important Instructions:

1. A candidate should report to the centre on time i.e. at 9:00 am on 13 May.

2. Aspirants should bring both original and photocopies of all the relevant documents. This includes a medical degree, age proof, experience certificate, etc.

3. They should submit an application on plain paper mentioning the post he/she has applied for.

4. Along with the application, five passport size photographs should also be submitted.

5. Those who clear the interview will move to the next stage i.e. medical examination.

Candidates applying for GDMO recruitment at Composite Hospital, CRPF, Group Centre Campus, Chandrayangutta, Barkas Hyderabad, can refer to the detailed advertisement here.

Aspirants interested in the walk-in-drive at Composite Hospital, CRPF, Pune, Maharashtra, can check all the important details in the notification here.

Eligibility Criteria:
1. A candidate must have an MBBS degree from a recognised university

2. He/She must have completed the MBBS internship

3. A candidate must not exceed 70 years of age

Further, aspirants are advised to regularly check the official CRPF website — crpf.gov.in — to access the latest notifications and updates regarding these posts.



from Firstpost India Latest News https://ift.tt/3evKfhC
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more